British Journal of Ophthalmology

health

New Study Links Wegovy to Nearly Fivefold Increase in Sudden Vision Loss Compared to Ozempic

Analysis of seven years of FDA data indicates Wegovy users face significantly higher risks of ischemic optic neuropathy compared to Ozempic patients.